Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.


Journal

Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727

Informations de publication

Date de publication:
08 2020
Historique:
received: 05 03 2020
revised: 03 04 2020
accepted: 10 04 2020
pubmed: 25 4 2020
medline: 22 12 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

Lysphosphatidic acid (LPA) is a major natural bioactive lipid mediator whose biological functions affect multiple organs. These include bone as demonstrated by global Lpar1-knockout mice (Lpar1

Identifiants

pubmed: 32330664
pii: S1388-1981(20)30107-4
doi: 10.1016/j.bbalip.2020.158715
pii:
doi:

Substances chimiques

Receptors, Lysophosphatidic Acid 0
lysophosphatidic acid receptor 1, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

158715

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Candide A Alioli (CA)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

Léa Demesmay (L)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France.

Sara Laurencin-Dalacieux (S)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

Nicolas Beton (N)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

Delphine Farlay (D)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France.

Helene Follet (H)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France.

Amri Saber (A)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

François Duboeuf (F)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France.

Jerold Chun (J)

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.

Richard Rivera (R)

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.

Daniel Bouvard (D)

Institute for Advance Biosciences, Grenoble, France.

Irma Machuca-Gayet (I)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France.

Jean-Pierre Salles (JP)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

Isabelle Gennero (I)

Centre de Physiopathologie de Toulouse Purpan INSERM UMR 1043, Toulouse, France.

Olivier Peyruchaud (O)

Pathophysiology, Diagnosis and treatments of bone diseases, INSERM UMR1033, Lyon, France. Electronic address: olivier.peyruchaud@inserm.fr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH